1-877-439-2744 Motherisk Helpline
1-800-436-8477 Morning Sickness
1-877-327-4636 Alcohol and Substance
1-866-937-7678 Exercise in Pregnancy
1-888-246-5840 HIV and HIV Treatment
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Cancer in Pregnancy ForumArchived Questions and Answers
This Forum has been the centre of an exceptional exchange of knowledge diagnosis, treatment, symptoms and other effects of cancer during pregnancy and lactation. All are welcome to review the Questions and Answers posted here, provided that they acknowledge and accept the important proviso and disclaimer below.
I am a haematologist from south Brazil (Porto Alegre)and have a patient (male)that had an acute miocardial infarction 8 years ago. In this moment your platelet count was 1,2 million/mm3. I start hydroxiurea and had a good response. Now, his wife intend to get pregnant and he ask me about the hydroxiurea X anagrelide risks. I dont find specific articles about this, only recomendation to suspend hydroxiurea 3 months before conception. Could you help me?
It seems that a patient with ET who has undergone myocardial infarction cannot discontinue the hydroxyurea. To our knowledge, there are no reports on damage to fetuses that were conceived when the fathers were taking hydroxyurea.